Global 3D Bioprinting Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Component (3D Bioprinters and Bioinks), Material (Living Cells, Hydrogels, and Extracellular Matrices), Application (Research Application and Clinical Application), an

Global 3D Bioprinting Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Component (3D Bioprinters and Bioinks), Material (Living Cells, Hydrogels, and Extracellular Matrices), Application (Research Application and Clinical Application), and Region (North America, Europe, Asia-Pacific, and Latin America, Middle East and Africa)

Market Overview:

3D bioprinting is a technology where bioinks, mixed with living cells, are printed in 3D to construct natural tissue-like three-dimensional structures. This technology can be used in various research areas, such as tissue engineering and new drug development.

According to Ken Research Analysis, the Global 3D Bioprinting Market was valued at ~US$ 1 billion in 2017. It is estimated to be ~US$ 2 billion in 2022 and is forecasted to reach a market size of ~US$ 5 billion, growing at a CAGR of ~15% owing to the rising demand from the manufacturing industry.

Several pharmaceutical firms are rapidly utilizing 3D bioprinting goods and technology in process of finding and developing new drugs. Compared to the conventional drug test process, 3D bioprinting allows the drug industry to test medications more affordably and safely, which acts as a driving factor for the growth of the market.

Due to uncontrollable processing parameters and different materials, the additive manufacturing method's accuracy varies between machines. A few monitoring techniques are available to assist producers in fulfilling their unique requirements by correcting these modifications. It has been challenging to create intricate and precise mathematical models using additive manufacturing, which acts as a major challenge for the market.

The market was positively impacted by the COVID-19 pandemic as various 3D Bioprinting communities are responding to the worldwide crises by offering their respective skills to ease the burden on the supply chain and governments. As the cases of COVID-19 are increasing day by day, there has been a shortage of materials for medical professionals as well as for the general public. One of the biggest issues is the lack of availability of test kits for COVID-19. Hence, various 3D bioprinting companies are manufacturing 3D printers and related software on a large scale.

Scope of the Report:

The 3D Bioprinting market is segmented by component, material, application, and region. In addition, the report also covers the market size for each of the four regions' 3D Bioprinting market. The revenue used to size and forecast the market for each segment is US$ billion.

Component

3D Bioprinters
Bioinks
Material
Living Cells
Hydrogels
Extracellular Matrices
Others
Application
Research Application
Clinical Application
Region
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Rest of Europe)
Asia Pacific (China, Japan, South Korea, India, Indonesia, Australia, Rest of Asia Pacific)
LAMEA (Latin America, Middle East, Africa)

Key Players

Organovo Holdings, Inc.
Inventia Life Science
Poietis
VIVAX BIO, LLC
CYFUSE BIOMEDICAL K.K.
3D Bioprinting Solutions
CELLINK
BICO - THE BIO CONVERGENCE COMPANY
CollPlant Biotechnologies Ltd.
Aspect Biosystems Ltd.

Key Trends

by Market Segment

By Component:

The 3D bioprinters segment held the largest market share in the global 3D bioprinting market in 2021, owing to the growing demand for 3D bioprinting due to the widespread use of pharmaceutical pills to treat a variety of chronic conditions.
Bioprinting is a form of additive manufacturing that uses biomaterials instead of traditional metals and plastics to create 3D tissues.
3D bioprinters use three-dimensional technology in combination with biocompatible materials to replicate body parts. It is used for bioprinting of tissue, bone, organs, blood vessels tissue, and biomedical parts.

By Material:
The living cells segment held the largest market share in the global 3D bioprinting market in 2021, owing to rising demand from the pharmaceutical industry.

Using living cells as bio-inks, the inkjet technology allows for the printing of complex organs and tissues on culture substrates.

Living tissues and organs can be printed in three dimensions by layering living cells. There is growing usage of living cells in regenerative medicine and stem cell research.

By Application:

The clinical application segment held the largest market share in the global 3D bioprinting market in 2021, owing to utilization of bioprinting technology in clinical trials of various diseases.

Bioprinting saves time in clinical trials and, thus, is being increasingly used for drug discovery. Biopharmaceutical companies are collaborating with market players to test their drugs.

By Region:
North Americaheld the largest market share among all other regions within the global 3D bioprinting market in 2021, due to the supporting government policies to augment the growth of the region.

The increasing incorporation of IT in the healthcare industry and increasing adoption of 3D bioprinting for the production of medical products is expected to be one of the major factors contributing to market growth in this region.

The USA government is spending more on research and development, in order to come up with vaccines for conditions like Covid and other diseases. Due to this reason, there is an increasing demand for 3D bioprinting, as this technology has been reconnoitered for drug testing and organ transplantation.

Competitive Landscape

The Global 3D Bioprinting Market is highly competitive with ~100 players, including globally diversified players, regional players, and many country-niche players. Most of the regional players are the developers of 3D Bioprinting used in various end-user industries.
Country-niche players constitute ~25% of the total number of competitors, while regional players dominate representing ~45% of total competitors. Some of the major players in the market include Organovo Holdings, Inc., Inventia Life Science, Poietis, VIVAX BIO, LLC, CYFUSE BIOMEDICAL K.K., 3D Bioprinting Solutions, CELLINK , BICO - THE BIO CONVERGENCE COMPANY, CollPlant Biotechnologies Ltd., Aspect Biosystems Ltd., among others.

Recent Developments Related to Major Players and Organizations

In March 2022, BICO Company AB, introduced the BIO CELLX, a revolutionary technology that automates 3D cell cultivation processes by utilizing prevalidated procedures.
In May 2021, 3D Systems, a US-based company engaged in offering 3D bioprinting technology announced the acquisition of Allevi Inc. Through the acquisition, 3D Systems plans to utilize Allevi’s expertise to develop applications in the future for the development of human organs in the long term and become a market leader in bioprinting.

Conclusion

The Global 3D Bioprinting Market witnessed a positive impact due to COVID-19 owing to the growing demand for 3D bioprinters from the healthcare and pharmaceutical industries. 3D bioprinters are the most common component of 3D bioprinting. Majorly, the living cells are used as material in the 3D bioprinting technology for carrying out clinical trials. Though the market is competitive with ~100 participants, regional players control the dominant share in the market and country-niche players also hold a significant share.

Note:

This is an On-Demand/Planned report, so the figures quoted here for market size estimate, forecast, growth, segment share, and competitive landscape are based on initial findings and might vary slightly in the actual report. Also, any required customizations can be covered to the best feasible extent for Pre-booking clients and report delivered within a maximum of 2 working weeks.

Key Topics Covered in the Report

Snapshot of Global 3D Bioprinting Market
Industry Value Chain and Ecosystem Analysis
Market size and Segmentation of the Global 3D Bioprinting Market
Historic Growth of Overall Global 3D Bioprinting Market and Segments
Competition Scenario of the Market and Key Developments of Competitors
Porter’s 5 Forces Analysis of Global 3D Bioprinting Industry
Overview, Product Offerings, Strengths, & Weaknesses of Key Competitors
Covid-19 Impact on the Overall Global 3D Bioprinting Market
Future Market Forecast and Growth Rates of the Global 3D Bioprinting Market and Segments
Analysis of Global 3D Bioprinting Market
Major Production/Supply and Consumption/Demand Hubs within Each Region
Major Country-wise Historic and Future Market Growth Rates of the Total Market and Segments
Overview of Notable Emerging Competitor Companies within Each Region

Notable Key Players Mentioned in the Report

Organovo Holdings, Inc.
Inventia Life Science
Poietis
VIVAX BIO, LLC
CYFUSE BIOMEDICAL K.K.
3D Bioprinting Solutions
CELLINK
BICO - THE BIO CONVERGENCE COMPANY
CollPlant Biotechnologies Ltd.
Aspect Biosystems Ltd.

Notable Emerging Companies Mentioned in the Report

Organovo
Prellis Biologics
Pandorum Technologies
Regenovo Biotechnology

Key Target Audience – Organizations and Entities Who Can Benefit by Subscribing This Report

3D Bioprinting Manufacturers
3D Bioprinting Suppliers
3D Bioprinters Manufacturers
Bioinks Manufacturers
Living Cells Suppliers
Hydrogels Suppliers
Extracellular Matrices Suppliers
3D Bioprinting Distributors
Emerging and Startup Companies in 3D Bioprinting
Different Types of 3D Bioprinting Manufacturing Hubs
Government Departments of Healthcare
Government Departments of Pharmaceuticals
Ministries and Departments of Bio-based Materials
Importers and Distributors of 3D Bioprinting

Period Captured in the Report

Historical Period: 2017-2021
Forecast Period: 2022E-2028F

Frequently Asked Questions

What is the Study Period of this Market Report?

The Global 3D Bioprinting Market is covered from 2017-2028 in this report, which includes a forecast for the period (2022-2028).

What is the Future Growth Rate of the Global 3D Bioprinting Market?

The global 3D Bioprinting market is expected to witness a CAGR of ~15% over the next 6 years.

What are the Key Factors Driving the Global 3D Bioprinting Market?

The high demand for tissues and organs for transplantation is one of the primary drivers for the growth of the global 3D bioprinting market.

Which is the Largest Application Segment within the Global 3D Bioprinting Market?

The clinical application segment held the largest share of the global 3D bioprinting market in 2021.

Who are the Key Players in the Global 3D Bioprinting Market?

Organovo Holdings, Inc., Inventia Life Science, Poietis, VIVAX BIO, LLC, CYFUSE BIOMEDICAL K.K., 3D Bioprinting Solutions, CELLINK, BICO - THE BIO CONVERGENCE COMPANY, CollPlant Biotechnologies Ltd., Aspect Biosystems Ltd., among others are the major companies operating in Global 3D Bioprinting Market.

Key Topics Covered in the Report

Snapshot of Global 3D Bioprinting Market
Industry Value Chain and Ecosystem Analysis
Market size and Segmentation of the Global 3D Bioprinting Market
Historic Growth of Overall Global 3D Bioprinting Market and Segments
Competition Scenario of the Market and Key Developments of Competitors
Porter’s 5 Forces Analysis of Global 3D Bioprinting Industry
Overview, Product Offerings, Strengths, & Weaknesses of Key Competitors
Covid-19 Impact on the Overall Global 3D Bioprinting Market
Future Market Forecast and Growth Rates of the Global 3D Bioprinting Market and Segments
Analysis of Global 3D Bioprinting Market
Major Production/Supply and Consumption/Demand Hubs within Each Region
Major Country-wise Historic and Future Market Growth Rates of the Total Market and Segments
Overview of Notable Emerging Competitor Companies within Each Region

Please Note: It will take 5-7 business days to complete the report upon order confirmation.